Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Risk factors

Sleep apnoea, atrial fibrillation, and heart failure—quo vadis?

Nature Reviews Cardiology volume 12, pages 263–264 (2015)Cite this article

Subjects

Strong associations exist between sleep disordered breathing (SDB) and both atrial fibrillation (AF) and heart failure (HF). Burgeoning epidemics of obesity, SDB, AF, and HF make these conditions priorities for health-care policymakers. Two observational studies now suggest outcome benefits from screening and treating for SDB in AF and HF.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Proposed pathophysiological components of obstructive sleep apnoea, activation of cardiovascular disease mechanisms, and consequent development of established cardiovascular disease.

References

  1. Somers, V. K. et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation scientific statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing: in collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118, 1080–1111 (2008).

    Article  Google Scholar 

  2. Holmqvist, F. et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation—results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am. Heart J. http://dx.doi.org/10.1016/j.ahj.2014.12.024.

  3. Khayat, R. et al. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/ehu522.

  4. Wolowacz, S. E., Samuel, M., Brennan, V. K., Jasso-Mosqueda, J. G. & Van Gelder, I. C. The cost of illness of atrial fibrillation: a systematic review of the recent literature. Europace 13, 1375–1385 (2011).

    Article  CAS  Google Scholar 

  5. Ziaeian, B., Sharma, P. P., Yu, T. C., Johnson, K. W. & Fonarow, G. C. Factors associated with variations in hospital expenditures for acute heart failure in the United States. Am. Heart J. 169, 282–289.e15 (2015).

    Article  Google Scholar 

  6. Braga, B. et al. Sleep-disordered breathing and chronic atrial fibrillation. Sleep Med. 10, 212–216 (2009).

    Article  CAS  Google Scholar 

  7. Albuquerque, F. N. et al. Sleep-disordered breathing and excessive daytime sleepiness in patients with atrial fibrillation. Chest 141, 967–973 (2012).

    Article  Google Scholar 

  8. Khayat, R. et al. Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. J. Card. Fail. 18, 534–540 (2012).

    Article  Google Scholar 

  9. Bradley, T. D. et al. Continuous positive airway pressure for central sleep apnea and heart failure. N. Engl. J. Med. 353, 2025–2033 (2005).

    Article  CAS  Google Scholar 

  10. Cowie, M. R. et al. Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure. Eur. J. Heart Fail. 15, 937–943 (2013).

    Article  Google Scholar 

Download references

Acknowledgements

V.K.S. is supported by NIH grant HL65176.

Author information

Authors and Affiliations

  1. Mayo Graduate School, Mayo Clinic, 200 First Street SW, Rochester, 55902, MN, USA

    C. Anwar A. Chahal

  2. Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, 55902, MN, USA

    Virend K. Somers

Authors
  1. C. Anwar A. Chahal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Virend K. Somers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Virend K. Somers.

Ethics declarations

Competing interests

V.K.S. declares that he has received grant support from Philips Respironics Foundation (gift to Mayo Foundation); is a consultant for GlaxoSmithKline, PricewaterhouseCoopers, ResMed, Respicardia, Rhonda Grey, and U-Health; and is working with Mayo Health Solutions and their industry partners on intellectual property related to sleep and cardiovascular disease. C.A.A.C. declares no competing interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chahal, C., Somers, V. Sleep apnoea, atrial fibrillation, and heart failure—quo vadis?. Nat Rev Cardiol 12, 263–264 (2015). https://doi.org/10.1038/nrcardio.2015.31

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2015.31

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing